FutureLand (FUTL) Subsidiary Signs Purchase and Sales Agreement to Purchase Licensed Medical Marijuana Facility

DENVER, CO–(Marketwired – March 16, 2016) – FutureLand Corp. (OTC PINK: FUTL), a leading provider of strategic real estate investment, grow facilities and material solutions to the global cannabis industry, announced today that FutureLand Oregon LLC., a subsidiary of FutureLand Corp., entered into a purchase and sale agreement to buy 40 acres of land in Southern Oregon. The land is currently operational as a licensed medical marijuana facility.

Cameron Cox, CEO of FutureLand Corp. said, “This marks an important milestone in our business plan and allows us to be one of the first public companies to enter the cultivation side of the business. As a result of the consulting agreement signed February 2, 2016 between Hemp, Inc.’s Industrial Hemp and Medical Marijuana Consulting Company and FutureLand Corp, I have been able to dialogue regularly with Bruce Perlowin, CEO of Hemp Inc. (OTC PINK: HEMP), as well as their consulting division, which has been instrumental in aiding us in making the decision to enter the market in this particular area. Specifically, Mr. Perlowin assisted us in identifying hemp farms in Oregon helping to mitigate any potential cross-pollinating threats.”

FutureLand Corp agreed to purchase the property for $975,000 in cash and expects to close in the second quarter of 2016. Once the purchase is complete, FutureLand plans to file for a recreational license on the property. Information concerning this event was filed by the Company today with the Securities and Exchange Commission and can be obtained at www.sec.gov.

About FutureLand Corp.

FutureLand Corp., a Colorado company, is a cannabis and hemp specialty zoned land leasing company formed to capitalize upon the emerging global cannabis market. FutureLand, focuses on target acquisition, zoning, license fulfillment, site plan preparation and financing of cannabis or hemp grow facilities throughout the United States. We give growers the opportunity to grow. We monetize through leasing the land, leasing the structures on the land, financing interest revenue and management fees associated with cultivation centers. FutureLand retains ownership of all the land and the structures. FutureLand leases to both medical marijuana, retail marijuana as well as industrial hemp growers. FutureLand does not currently grow, distribute or sell marijuana. To request further information about FutureLand, please email us at info@futurelandcorp.com, log onto our website at http://www.futurelandcorp.com, or visit us on FB @ futurelandcorp and Twitter @futurelandcorp.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

This press release may contain forward-looking statements covered within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of our services and products, statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release that are not historical fact and involve risks and uncertainties. Our expectations regarding future revenues depend upon our ability to develop and supply products and services that we may not produce today and that meet defined specifications. When used in this press release, the words “plan,” “expect,” “believe,” and similar expressions generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties, including, but not limited to, changes in technology and changes in pervasive markets. This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.